“Telithromycin (Ketek®)in Lower Respiratory Tract Infections: Economic Aspects ”. 2006. Farmeconomia. Health Economics and Therapeutic Pathways 7 (2): 89-96. https://doi.org/10.7175/fe.v7i2.679.